open access

Vol 86, No 5 (2018)
ORIGINAL PAPERS
Published online: 2018-10-30
Submitted: 2018-07-29
Accepted: 2018-09-11
Get Citation

Influence of particulate matter air pollution on exacerbation of chronic obstructive pulmonary disease depending on aerodynamic diameter and the time of exposure in the selected population with coexistent cardiovascular diseases

Michał Zieliński, Mariusz Gąsior, Dariusz Jastrzębski, Aneta Desperak, Dariusz Ziora
DOI: 10.5603/ARM.2018.0036
·
Pubmed: 30378650
·
Adv Respir Med 2018;86(5):227-233.

open access

Vol 86, No 5 (2018)
ORIGINAL PAPERS
Published online: 2018-10-30
Submitted: 2018-07-29
Accepted: 2018-09-11

Abstract

Introduction: Particulate matter air pollution constitutes an important factor affecting the course of various respiratory and cardiovascular
diseases. Two main monitored groups of particulate pollution are particulate matter with the aerodynamic diameter
below 10 μm (PM10) and 2.5 μm (PM2.5). One of the most important respiratory diseases is chronic obstructive pulmonary
disease (COPD). Clinical presentation of COPD and cardiovascular diseases is similar and can cause complications during therapy.
The study explores connection between particulate matter and COPD exacerbations in population with cardiovascular cause of
symptoms excluded.

Material and methods: Analysis was based on data from hospitalisations in the years 2006-2016 in the hospitals of Upper
Silesian Agglomeration, Poland. The data were correlated with meteorological conditions and particulate matter concentrations
up to 90 days before hospital admission.

Results: During the whole observation period no connection between PM10 concentration changes and COPD exacerbations
were observed. On the other hand PM 2,5 influence started to be significant on 14 day before admission (RR 1.06) and increased
up to maximal analysed period of 90 days (RR 1.32).

Conclusions: Overall this study highlights the importance of particulate matter pollution emission impact on COPD exacerbations
in a long time perspective.

Abstract

Introduction: Particulate matter air pollution constitutes an important factor affecting the course of various respiratory and cardiovascular
diseases. Two main monitored groups of particulate pollution are particulate matter with the aerodynamic diameter
below 10 μm (PM10) and 2.5 μm (PM2.5). One of the most important respiratory diseases is chronic obstructive pulmonary
disease (COPD). Clinical presentation of COPD and cardiovascular diseases is similar and can cause complications during therapy.
The study explores connection between particulate matter and COPD exacerbations in population with cardiovascular cause of
symptoms excluded.

Material and methods: Analysis was based on data from hospitalisations in the years 2006-2016 in the hospitals of Upper
Silesian Agglomeration, Poland. The data were correlated with meteorological conditions and particulate matter concentrations
up to 90 days before hospital admission.

Results: During the whole observation period no connection between PM10 concentration changes and COPD exacerbations
were observed. On the other hand PM 2,5 influence started to be significant on 14 day before admission (RR 1.06) and increased
up to maximal analysed period of 90 days (RR 1.32).

Conclusions: Overall this study highlights the importance of particulate matter pollution emission impact on COPD exacerbations
in a long time perspective.

Get Citation

Keywords

air pollution, particulate matter, COPD exacerbations, cardiovascular comorbidities

About this article
Title

Influence of particulate matter air pollution on exacerbation of chronic obstructive pulmonary disease depending on aerodynamic diameter and the time of exposure in the selected population with coexistent cardiovascular diseases

Journal

Advances in Respiratory Medicine

Issue

Vol 86, No 5 (2018)

Pages

227-233

Published online

2018-10-30

DOI

10.5603/ARM.2018.0036

Pubmed

30378650

Bibliographic record

Adv Respir Med 2018;86(5):227-233.

Keywords

air pollution
particulate matter
COPD exacerbations
cardiovascular comorbidities

Authors

Michał Zieliński
Mariusz Gąsior
Dariusz Jastrzębski
Aneta Desperak
Dariusz Ziora

References (37)
  1. Air quality guidelines. Global update 2005. Particulate matter, ozone, nitrogen dioxide and sulfur dioxide. WHO Press, Geneva, 2005.
  2. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–2260.
  3. Ko FW, Chan KaP, Hui DS, et al. Acute exacerbation of COPD. Respirology. 2016; 21(7): 1152–1165.
  4. Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57(10): 847–852.
  5. Ni L, Chuang CC, Zuo Li. Fine particulate matter in acute exacerbation of COPD. Front Physiol. 2015; 6: 294.
  6. Forbes LJL, Kapetanakis V, Rudnicka AR, et al. Chronic exposure to outdoor air pollution and lung function in adults. Thorax. 2009; 64(8): 657–663.
  7. Guo C, Zhang Z, Lau AKH, et al. Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan: a longitudinal, cohort study. Lancet Planet Health. 2018; 2(3): e114–e125.
  8. Karakatsani A, Analitis A, Perifanou D, et al. Particulate matter air pollution and respiratory symptoms in individuals having either asthma or chronic obstructive pulmonary disease: a European multicentre panel study. Environ Health. 2012; 11: 75.
  9. Casas L, Simons K, Nawrot TS, et al. Respiratory medication sales and urban air pollution in Brussels (2005 to 2011). Environ Int. 2016; 94: 576–582.
  10. Tamayo-Uria I, Altzibar JM, Mughini-Gras L, et al. Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Ecological Study in the Basque Country, Spain (2000-2011). COPD. 2016; 13(6): 726–733.
  11. Faustini A, Stafoggia M, Colais P, et al. EpiAir Collaborative Group. Air pollution and multiple acute respiratory outcomes. Eur Respir J. 2013; 42(2): 304–313.
  12. Liu Y, Yan S, Poh K, et al. Impact of air quality guidelines on COPD sufferers. Int J Chron Obstruct Pulmon Dis. 2016; 11: 839–872.
  13. Hawkins NM, Petrie MC, Jhund PS, et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009; 11(2): 130–139.
  14. Liu Y, Yan S, Poh K, et al. Impact of air quality guidelines on COPD sufferers. Int J Chron Obstruct Pulmon Dis. 2016; 11: 839–872.
  15. Wu S, Ni Y, Li H, et al. Short-term exposure to high ambient air pollution increases airway inflammation and respiratory symptoms in chronic obstructive pulmonary disease patients in Beijing, China. Environ Int. 2016; 94: 76–82.
  16. Karakatsani A, Analitis A, Perifanou D, et al. Particulate matter air pollution and respiratory symptoms in individuals having either asthma or chronic obstructive pulmonary disease: a European multicentre panel study. Environ Health. 2012; 11: 75.
  17. DeVries R, Kriebel D, Sama S. Low level air pollution and exacerbation of existing copd: a case crossover analysis. Environ Health. 2016; 15(1): 98.
  18. Moore E, Chatzidiakou L, Kuku MO, et al. Global Associations between Air Pollutants and Chronic Obstructive Pulmonary Disease Hospitalizations. A Systematic Review. Ann Am Thorac Soc. 2016; 13(10): 1814–1827.
  19. DeVries R, Kriebel D, Sama S. Outdoor Air Pollution and COPD-Related Emergency Department Visits, Hospital Admissions, and Mortality: A Meta-Analysis. COPD. 2017; 14(1): 113–121.
  20. Aga E, Samoli E, Touloumi G, et al. Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology. 2001; 12(5): 521–531.
  21. Laden F, Neas LM, Dockery DW, et al. Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect. 2000; 108(10): 941–947.
  22. Bell ML, Ebisu K, Peng RD, et al. Hospital admissions and chemical composition of fine particle air pollution. Am J Respir Crit Care Med. 2009; 179(12): 1115–1120.
  23. Casas L, Simons K, Nawrot TS, et al. Respiratory medication sales and urban air pollution in Brussels (2005 to 2011). Environ Int. 2016; 94: 576–582.
  24. Magzamen S, Oron AP, Locke ER, et al. Association of ambient pollution with inhaler use among patients with COPD: a panel study. Occup Environ Med. 2018; 75(5): 382–388.
  25. Li R, Jiang N, Liu Q, et al. Impact of Air Pollutants on Outpatient Visits for Acute Respiratory Outcomes. Int J Environ Res Public Health. 2017; 14(1).
  26. Wang KY, Chau TT. An association between air pollution and daily outpatient visits for respiratory disease in a heavy industry area. PLoS One. 2013; 8(10): e75220.
  27. McCormack MC, Belli AJ, Waugh D, et al. Respiratory Effects of Indoor Heat and the Interaction with Air Pollution in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016; 13(12): 2125–2131.
  28. Bernstein AS, Rice MB. Lungs in a warming world: climate change and respiratory health. Chest. 2013; 143(5): 1455–1459.
  29. Liang WM, Liu WP, Kuo HW. Diurnal temperature range and emergency room admissions for chronic obstructive pulmonary disease in Taiwan. Int J Biometeorol. 2009; 53(1): 17–23.
  30. Ferrari U, Exner T, Wanka ER, et al. Influence of air pressure, humidity, solar radiation, temperature, and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, Germany. Int J Biometeorol. 2012; 56(1): 137–143.
  31. Almagro P, Hernandez C, Martinez-Cambor P, et al. Seasonality, ambient temperatures and hospitalizations for acute exacerbation of COPD: a population-based study in a metropolitan area. Int J Chron Obstruct Pulmon Dis. 2015; 10: 899–908.
  32. Chen Y, Zang Lu, Du W, et al. Ambient air pollution of particles and gas pollutants, and the predicted health risks from long-term exposure to PM in Zhejiang province, China. Environ Sci Pollut Res Int. 2018 [Epub ahead of print].
  33. Wen CP, Gao W. PM: an important cause for chronic obstructive pulmonary disease? Lancet Planet Health. 2018; 2(3): e105–e106.
  34. Rovira J, Sierra J, Nadal M, et al. Main components of PM in an area influenced by a cement plant in Catalonia, Spain: Seasonal and daily variations. Environ Res. 2018; 165: 201–209.
  35. Sinharay R, Gong J, Barratt B, et al. Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study. Lancet. 2018; 391(10118): 339–349.
  36. Liu Yi, Sun J, Gou Y, et al. A Multicity Analysis of the Short-Term Effects of Air Pollution on the Chronic Obstructive Pulmonary Disease Hospital Admissions in Shandong, China. Int J Environ Res Public Health. 2018; 15(4).
  37. Bloemsma LD, Hoek G, Smit LAM. Panel studies of air pollution in patients with COPD: Systematic review and meta-analysis. Environ Res. 2016; 151: 458–468.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl